There were two RCT publications which reported urinary GL-3 levels in MG populations: one reported an overall decrease [176], and the other a trend towards decline, with agalsidase alfa 0.2 mg/kg weekly [135]. This evidence concerns the gene GLA and myasthenia gravis.